Phio Pharmaceuticals Corp. (PHIO) Key Statistics & Metrics
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
- Shares outstanding
- —
- Float
- —
- Free float
- —
- EPS (TTM)
- —
PHIO stock: frequently asked questions
What is PHIO's ST Score?
Phio Pharmaceuticals Corp. (PHIO) has an ST Score of 47.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PHIO a buy, hold, or sell?
Analysts rate PHIO a Buy. Our ST Score grades it C+ (47.1/100). The ST Score is a data-driven signal, not a recommendation.
What are PHIO's factor grades?
Valuation B-, Profitability D-, Financial Strength A+, Momentum C, Growth B+.
What is PHIO's valuation grade?
Phio Pharmaceuticals Corp. (PHIO) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PHIO's growth grade?
Phio Pharmaceuticals Corp. (PHIO) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PHIO's profitability grade?
Phio Pharmaceuticals Corp. (PHIO) earns a profitability grade of D-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PHIO's financial strength grade?
Phio Pharmaceuticals Corp. (PHIO) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is PHIO's Piotroski score?
Phio Pharmaceuticals Corp. (PHIO) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.